Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Basic Clin Pharmacol Toxicol ; 123(6): 721-726, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29964362

RESUMO

The objective of this study was to evaluate the effect of apatinib on the pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in SD rats and the inhibitory effects of apatinib on venlafaxine in rat and human liver microsomes. Twenty-one SD male rats were randomly divided into three groups (n = 7): group A (multiple dose of 40 mg/kg apatinib for 7 days), group B (single dose of 40 mg/kg apatinib) and group C (the control group). All samples were measured by UPLC-MS/MS. The results indicated that a single dose of apatinib increased the AUC(0-t) , AUC(0-∞) and Cmax of both venlafaxine and O-desmethylvenlafaxine significantly, while Vz/F and CLz/F were decreased. As for group A, only AUC(0-t) and CLz/F of venlafaxine were changed, while no parameters of O-desmethylvenlafaxine were altered. In addition, apatinib was determined to be a mixed inhibitor of venlafaxine.


Assuntos
Succinato de Desvenlafaxina/farmacocinética , Inibidores de Proteínas Quinases/farmacologia , Piridinas/farmacologia , Cloridrato de Venlafaxina/farmacocinética , Animais , Cromatografia Líquida de Alta Pressão , Succinato de Desvenlafaxina/sangue , Interações Medicamentosas , Humanos , Concentração Inibidora 50 , Masculino , Espectrometria de Massas , Microssomos Hepáticos/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Cloridrato de Venlafaxina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...